On April 9, the 93rd China International Medical Equipment Fair (CMEF 2026) grandly opened at the Shanghai National Convention and Exhibition Center. As one of the global innovation leaders in pulse oximetry, ChoiceMMed presented its comprehensive product portfolio at CMEF, offering a three-dimensional view of its health protection solutions spanning from clinical settings to home care.

Hospital & Clinical Care: Diving Deep with Cutting-Edge Technology 

Addressing the needs of domestic hospital and clinical care, ChoiceMMed unveiled three major solution suites–Smart Monitoring, Respiratory Health, and Primary Public Health–targeting clinical pain points from mobile monitoring to smart healthcare, delivering precise and efficient support for diverse medical scenarios. 

-Smart Monitoring Solution 

The centerpiece,the Multi-Parameter Telemetry Monitoring System, wirelessly tracks seven physiological parameters and provides synchronized alerts on a central workstation, achieving an optimal balance between patient comfort and nursing efficiency.

-Respiratory Health Solution 

From sleep apnea screening via wrist-worn oximeters to quiet oxygen delivery by intelligent medical oxygen concentrators, and rehabilitation support with respiratory trainers–this closed-loop solution embodies full-cycle respiratory health management.

-Primary Public Health Solution 

The all-in-one health check station series integrates professional diagnostics with telemedicine, bringing quality medical resources to the grassroots level. It offers integrated, smart health management applications for primary care institutions.

Home Care: Attention to Detail, Companionship in Care 

With over 30 years of deep cultivation in overseas home care markets, ChoiceMMed leverages its three core product lines–oximetry, respiratory,and cardiovascular–and follows an innovation path focused on portability, wearability,and intelligence. It integrates professional medical capabilities into daily health management scenarios, continuously expanding the breadth and depth of care.

In the home respiratory health zone, ChoiceMMed's fingertip pulse oximeters provide accurate SpO₂ monitoring and integrate multi-dimensional data such as pulse rate, respiration rate, and heart rate variability(HRV). This enables combined multi-parameter assessment, offering new insights for early detection of chronic respiratory diseases and cardiovascular risks.

In the cardiovascular and smart health zone, the compact and portable Card ECG Monitor completes heart rate, ECG waveform detection, and atrial fibrillation risk analysis in just 30 seconds. The results can serve as a reference for doctors' diagnoses, addressing the challenge of capturing paroxysmal atrial fibrillation–making cardiovascular health management truly "measurable anytime, with peace of mind." 

Live Impressions: Resonating Care Behind the Hype 

On the opening day, the ChoiceMMed booth was bustling with visitors eager to inquire and experience the products. Professional attendees engaged in deep discussions about the Multi-Parameter Telemetry Monitoring System, while overseas customers showed sustained interest in future medical innovation scenarios. The event became a hub for technical exchange and conceptual collisions, where technology is no longer cold data but a warm force that senses, prevents, and protects.

As a core enterprise within Tianjin Chasesun Pharmaceutical Co., Ltd.'s medical device segment, ChoiceMMed is driven by technological innovation and leverages the R&D and channel strengths of its parent company. By continually advancing in home health management and smart medical monitoring, ChoiceMMed has built deep technical expertise and a solid market foundation, evolving from point breakthroughs to systematic capabilities. 

The collective debut of this innovative product matrix vividly demonstrates the effective internal resource integration and strategic synergy within Tianjin Chasesun. Building on its strengthened technological foundation and market presence, ChoiceMMed will further deepen collaboration and coordination with various subsidiaries of Tianjin Chasesun. By pooling resources and complementing each other's strengths, they aim to jointly build a highly synergistic and innovation-led medical device business segment, empowering global health with more competitive products and solutions.